A Case of High Dose Oseltamivir Treatment in an Influenza A (H1N1) Infected Patient with Severe Graft Versus Host Disease / 임상소아혈액종양
Clinical Pediatric Hematology-Oncology
;
: 58-61, 2011.
Artigo
em Coreano
| WPRIM
| ID: wpr-788428
ABSTRACT
Influenza A (H1N1) infection has been noted to be common in the young and high-risk groups for influenza infection, including transplant candidates and recipients. However, the optimal dosage and duration of oseltamivir for severely immunocompromised patients have not been defined. We report the case of a patient with relapsed neuroblastoma who was infected with influenza A (H1N1) and suffered from skin and lung graft versus host disease after he had received allogeneic hematopoietic stem cell transplantation from a matched sibling donor. During the immunosuppressant therapy, he was diagnosed with influenza A (H1N1) infection by real time polymerase chain reaction (RT-PCR). He recovered after oseltamivir treatment with a dosage of 90 mg twice a day for two weeks, which was two times of the standard dose until influenza A (H1N1) RT-PCR was proven to be negative.
Texto completo:
DisponíveL
Índice:
WPRIM (Pacífico Ocidental)
Assunto principal:
Pele
/
Doadores de Tecidos
/
Hospedeiro Imunocomprometido
/
Transplante de Células-Tronco Hematopoéticas
/
Transplantes
/
Irmãos
/
Influenza Humana
/
Vírus da Influenza A Subtipo H1N1
/
Oseltamivir
/
Reação em Cadeia da Polimerase em Tempo Real
Limite:
Humanos
Idioma:
Coreano
Revista:
Clinical Pediatric Hematology-Oncology
Ano de publicação:
2011
Tipo de documento:
Artigo
Similares
MEDLINE
...
LILACS
LIS